Taking GlyNAC for 16 weeks significantly improves insulin sensitivity in older adults with obesity, bringing it back to levels normally seen in younger people.
Scientific Claim
GlyNAC supplementation (100 mg/kg/day each of glycine and N-acetylcysteine) for 16 weeks in older adults with BMI >27 improved insulin resistance by 64% as measured by HOMA-IR, restoring levels to those seen in young adults.
Original Statement
“GlyNAC supplementation in OA significantly lowered IR and fasting insulin concentrations after 2-weeks (HOMA-IR 31%; fasting insulin 34%), and after 16-weeks (HOMA-IR 64%; fasting insulin 65%) to values not different from YA-0w”
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
definitive
Can make definitive causal claims
Assessment Explanation
This is a randomized controlled trial with direct measurements of insulin resistance before and after intervention. The study design supports causal claims about the specific outcome measured in this population.